Ποια είναι η τιμή για Canton Strategic Holdings Inc (CNTN)

Η τιμή για Canton Strategic Holdings Inc (CNTN) είναι $2.29

Ποια είναι η κεφαλαιοποίηση αγοράς για Canton Strategic Holdings Inc (CNTN)

Η κεφαλαιοποίηση αγοράς για Canton Strategic Holdings Inc (CNTN) είναι $176.61M

Canton Strategic Holdings Inc (CNTN) Τιμή και Κεφαλαιοποίηση Αγοράς

Canton Strategic Holdings Inc., which was formerly known as Tharimmune, Inc. until its name change in February 2026, focuses on two primary areas. The company is committed to promoting the institutional integration of blockchain technology and fostering the digitization of financial markets, primarily by leveraging Canton Coin and offering support to the Canton network. In addition to its blockchain initiatives, the company is also deeply involved in pharmaceutical research and development. Its pipeline includes GV104, a buccal film technology designed to address respiratory and/or nervous system depression in military personnel and chemical incident responders, which has already finished its Phase 1 trial. Another significant project is GV023, an oral version of infliximab, engineered to resolve the key inconvenience of the standard intravenous treatment by eliminating the need for recurring infusions. Established in 2017, Canton Strategic Holdings Inc. is headquartered in Red Bank, New Jersey.

Η τιμή για CNTN	Το περιουσιακό στοιχείο B	Η κεφαλαιοποίηση αγοράς του B	Αποτελέσματα
$66,687.18 $176.61M	NVDA	$5.143T	+2,912,003.78%
$59,305.45 $176.61M	AAPL	$4.574T	+2,589,657.80%
$54,027.51 $176.61M	GOOG	$4.167T	+2,359,179.82%
$47,650.18 $176.61M	MSFT	$3.675T	+2,080,693.84%
$36,285.87 $176.61M	AMZN	$2.798T	+1,584,435.63%

Η τιμή για CNTN

Το περιουσιακό στοιχείο B

Η κεφαλαιοποίηση αγοράς του B

Αποτελέσματα

$66,687.18 $176.61M